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Abstract: Histological and functional changes associated with involution in the mammary gland are partly regulated by changes in 
gene expression. At 42 d postpartum, Holstein cows underwent a period of 5 d during which they were milked 1X daily until complete 
cessation of milking. Percutaneous mammary biopsies (n = 5/time point) were obtained on d 1, 5, 14, and 21 relative to the start 
of 1X milking for transcript profiling via qPCR of 57 genes associated with metabolism, apoptosis/proliferation, immune response/
inflammation, oxidative stress, and tissue remodeling. Not surprisingly, there was clear downregulation of genes associated with milk 
fat synthesis (FASN, ACACA, CD36, FABP3, SCD) and lipid-related transcription regulation (SREBF1, SREBF2). Similar to milk fat 
synthesis-related genes, those encoding proteins required for glucose uptake (SLC2A1), casein synthesis (CSN2, CSN3), and lactose 
synthesis (LALBA) decreased during involution. Unlike metabolic genes, those associated with immune response and inflammation (C3, 
LTF, SAA3), oxidative stress (GPX1, SOD2), and pro-inflammatory cytokine signaling (SPP1, TNF) increased to peak levels by d 14 
from the start of 1X milking. These adaptations appeared to be related with tissue remodeling as indicated by upregulation of proteins 
encoding matrix proteinases (MMP2), IGFBP3, and transcriptional regulation of apoptosis/cell proliferation (MYC). In contrast, the 
concerted upregulation of STAT3, TGFB1, and TGFB1R during the first 14 d was suggestive of an activation of these signaling pathways 
probably as an acute response to regulate differentiation and/or mammary cell survival upon the onset of a marked pro-inflammatory 
and oxidative stress response induced by the gradual reduction in milk removal. Results suggest a central role of STAT3, MYC, PPARG, 
SREBF1, and SREBF2 in regulating concerted alterations in metabolic and cell survival mechanisms, which were induced partly via 
oxidative stressed-triggered inflammation and the decline in metabolic activity.
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Involution  is  the  normal  process  by  which  the 
mammary gland returns to its non-lactating state.1,2 
Proposed  mechanisms  of  involution  include  local 
chemical feedback by milk constituents, formation 
of other substances in stored milk, milk stasis and 
udder distention, and stretching of the cells that lead 
to the loss of secretory activity.3,4 At the tissue level, 
the process of mammary gland involution involves 
invasion of leukocytes, increased epithelial cell death 
(through apoptosis or autophagy), and/or proliferation 
of connective tissue.5–7 Unlike the mouse, relatively 
little research in the cow has employed gene expression 
technologies such as microarray and/or quantitative 
RT-PCR  (qPCR)8,9  to  study  the  molecular  events 
associated with involution. Those studies conducted to 
date in cows undergoing normal or forced involution 
(ie, after sudden cessation of milking) have shown 
downregulation of mRNA abundance and concentra-
tion of enzymes related to the synthetic capacity of 
epithelial cells,7 downregulation of milk protein gene 
expression, upregulation of mRNA and synthesis of 
lactotransferrin,10,11 and upregulation of pro-apoptotic 
proteins (BAX) coupled with downregulation of beta 
integrins.8
Several transcription regulators coordinating the 
process of involution, namely in non-ruminants, have 
been identified. For example, signal transducer and 
activator  of  transcription  3  (acute-phase  response 
factor)  (STAT3)  was  postulated  as  a  death  factor 
in  differentiated  mouse  mammary  epithelium.12 
Upregulation  of  STAT3  has  been  observed  during 
involution in bovine9 and ovine13 mammary tissue. 
Transgenic mouse research demonstrated that v-myc 
myelocytomatosis  viral  oncogene  homolog  (avian) 
(MYC) functions to enhance apoptosis and involution 
in the mammary gland.14 Transforming growth factor, 
beta 1 (TGFB1) stimulates apoptosis (programmed 
cell death type I) as well as autophagy (programmed 
cell  death  type  II)  in  bovine  mammary  cells.6  Its 
synthesis increases during the dry period in cows15 and 
it is controlled partly by somatotropic-axis hormones, 
eg, in vitro studies in mammary epithelial cells dem-
onstrated  that  TGFB1  expression  is  increased  by 
estradiol and progesterone, while it is decreased by 
GH and IGF-1.16
A  recent  microarray  study  of  the  involution 
process  in  the  short-term  following  cessation  of 
milking revealed a strong upregulation of immune 
and antioxidant-related genes.9 Although these results 
were indicative of novel features of the involution 
process,  statistical  analysis  of  microarray  data  did 
not  seem  to  include  a  multiple  testing  correction 
of  the  raw  P-values.17  Furthermore,  there  was  no 
evaluation of suitable internal control genes (ICG) for 
normalization of qPCR data. The primary objective 
of the present study was to specifically evaluate the 
temporal  expression  of  gene  networks  associated 
with metabolism, transcriptional control of apoptosis 
and cell proliferation, mammary tissue remodeling, 
and immune/inflammatory response both in the short-
term after shifting from 2X to 1X daily milking (5 d) 
and 9 and 16 d (long-term) after complete cessation 
of milking. To that end, we first performed a search of 
suitable ICG18 that could be used to normalize mRNA 
abundance  data  from  this  type  of  studies.  Finally, 
milk production and composition during 1X milking 
and blood profiles of metabolites and insulin before 
and after cessation of milking were measured and 
related to gene expression patterns.
Materials and Methods
Animals and sampling
All  procedures  were  conducted  under  pro-
tocols  approved  by  the  University  of  Illinois 
Institutional  Animal  Care  and  Use  Committee. 
Twelve Holstein cows were milked twice daily (0600 
and 1700 h) until 42 d postpartum. For a period of 
5 d cows were milked once daily (0600 h) and then 
dried-off (complete cessation of milking). To ensure 
that  quarters  to  be  biopsied  were  healthy,  several 
measurements were considered: 1) a California Mas-
titis Test (CMT) was conducted before the last milk-
ing to rule out subclinical mastitis; 2) a milk sample 
from each quarter on the last milking was collected 
for  bacteriological  culture  (McConkey  agar  and 
Blood Agar) to assure bacteriological health; and 3) 
during the last 8 d of milking, somatic cell count (SCC, 
cells/mL; DHIA Laboratory, Dairy One, Ithaca, NY) 
was measured and evaluated as an indicator of udder 
health. As a prophylactic measure, each quarter was 
infused  with  intramammary  cephapirin  benzathine 
(Cefa-Dri®, Fort Dodge Animal Health, Division of 
Wyeth) following the last milking. Individual body 
weights were recorded at the beginning and at the end 
of the study.
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each  milking.  Milk  samples  for  composition  were 
collected the last 3 d of twice-a-day milking and the 
5 d of once-a-day milking. A composite sample based 
on milk yield was obtained when cows were being 
milked twice a day (at 0600 and 1700 h). Samples 
were stored with Bronopol® preservative at 4 °C prior 
to analysis of fat, protein, lactose, urea-N (MUN), 
and  somatic  cell  count  (SCC)  (cells/mL)  (DHIA 
Laboratory, Dairy One, Ithaca, NY).
Blood was collected from the coccygeal vein to 
isolate serum for metabolite analysis. Samples were 
taken daily from the last day of twice-a-day milking 
(d -1) until d 21, and centrifuged for 20 min at 2,000 
rpm after allowing the clot to form. Samples at d 1, 5, 
14, and 21 were used to determine concentrations of 
total protein, glucose, hydroxybutyrate (BHBA), and 
non-esterified fatty acids (NEFA) using commercial 
kits  at  the  Clinical  Pathology  Laboratory  of  the 
School of Veterinary Medicine, University of Illinois. 
Samples were taken prior to biopsies to avoid any 
confounding effect of the procedure on variables of 
interest. Insulin was measured at d 1 and 14 using 
a commercial bovine insulin ELISA kit (Mercodia, 
Uppsala, Sweden).
Mammary gland biopsies
Mammary gland tissue was harvested on d 1, 5, 14, and 
21 (n = 5/time point) from the initiation of 1X daily 
milking  via  percutaneous  biopsy.18  The  procedure 
was conducted under mild general anesthesia with 
Xylazine (Phoenix Pharmaceutical, Inc., St. Josephs, 
MO;  0.75  mL  total  intravenously;  20%  solution) 
and local anesthesia with lidocaine HCl (5 mL total 
subcutaneously; 2% solution). The midpoint area to 
either side of the udder was clipped and surgically 
scrubbed before biopsy. A 3-cm incision was made 
through the skin and subcutaneous tissue, which was 
afterwards detached from the mammary capsule at 
the site of incision. A clear image of the capsule was 
always necessary to introduce the biopsy instrument 
to  prevent  it  from  tangling  with  the  subcutaneous 
tissue. A core of mammary tissue was removed from 
rotating a trocar that was attached to a cordless drill 
at  high  speed  and  pushing  into  the  udder.19  Once 
the core was cut, the retractable blade was extended 
and  rotated  for  3–4  seconds  to  sever  the  core  of 
tissue. The capsule was not cut at any time prior to 
introducing  the  trocar.  Pressure  was  applied  with 
sterile gauze to the biopsy point until bleeding ceased. 
Eleven-mm Michel wound clips (#9534503, Henry 
Stein, Inc., Melville, NY) were used to close the skin 
incision, which was then covered with iodine oint-
ment (#1048023, Povidone Ointment, Henry Schein, 
Inc., Melvine, NY). Portions of extracted tissue were 
weighed  for  immediate  homogenization  in  5  mL 
ice-cold TRIzol reagent (Invitrogen, Carlsbad, CA), 
snap-freezing in liquid-N2 and storage at −80 °C until 
use. Homogenized samples were stored at −80 °C 
until RNA extraction.
Extraction and purification of total  
rNA, cDNA synthesis, evaluation  
of ICG, and qPCr
Total  RNA  was  extracted  from  mammary  gland 
samples  and  purified  using  the  RNeasy  Mini  Kit 
(Qiagen,  Valencia,  CA,  USA).  Residual  DNA  was 
removed  with  the  RNase-Free  DNase  Set  (Qiagen, 
Valencia, CA, USA). RNA concentration was measured 
using  a  NanoDrop  ND-1000  spectrophotometer 
(NanoDrop Technologies). The purity of RNA (A260/
A280) was above 2.0. RNA quality was assessed using 
a 2100 Bioanalyzer (Agilent Technologies). Samples 
had a median RNA integrity value of 8.06 ± 0.15.
Primers  were  designed  with  Primer  Express 
software  version  3.0  (Applied  Biosystems,  Foster 
City,  CA,  USA)  using  default  settings,  except 
for  amplicon  length  (100–150  bp).  Primers  were 
designed across exon/exon junctions when possible 
and  were  aligned  against  public  databases  using 
BLAST  software  available  at  National  Center  for 
Biotechnology Information (NCBI) (Suppl. Table 1). 
When  designing  primers,  primer  specificity  and 
absence  of  primer-dimers  were  evaluated.  Evalu-
ation  of  primers  was  performed  using  3  separate 
tests: 1) PCR products were visualized in a 2% aga-
rose gel (Invitrogen) stained with ethidium bromide 
to check for the absence of primer-dimers and the 
presence of bands at the respective amplicon size; 
2) PCR products were sequenced at the Core DNA 
Sequencing Facility of the Roy J. Carver Biotech-
nology Center at the University of Illinois, Urbana-
Champaign, and resulting data were aligned against 
the NCBI nucleotide database (Suppl. Table 2); and 
3) the presence of a single PCR product was verified 
by the occurrence of a single peak in the dissociation 
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passed all required tests.
Target genes
Fifty-seven  genes  encompassing  networks  with 
central  biological  functions  during  involution  in 
non-ruminants  were  evaluated  (Fig.  1).  Several  of 
these genes have known relationships in, pathways 
which coordinate metabolism in mammary cells as 
well as tissue remodeling. A portion of the assessed 
RNA was diluted to 100 mg/L using DNase/RNase 
free water prior to cDNA synthesis. Sufficient cDNA 
was prepared at the outset to run all selected genes. 
Each  cDNA  was  synthesized  by  RT  using  100  ng 
RNA, 1 µg dT18 (Operon Biotechnologies, AL), 1 µL 
10  mmol/L  dNTP  mix  (Invitrogen),  1  µL  Random 
Primers  (Invitrogen),  and  7  µL  DNase/RNase  free 
water. The mixture was incubated at 65 °C for 5 min 
and kept on ice for 3 min. A total of 9 µL of Master 
Mix composed of 4.5 µL 5X First-Strand Buffer, 1 µL 
0.1 M DTT, 0.25 µL (100 U) of SuperScriptTM III RT 
(Invitrogen), 0.25 µL of RNase Inhibitor (Promega), 
3 µL DNase/RNase free water was added. The reaction 
was performed in an Eppendorf Mastercycler® Gradient 
using the following temperature program: 25 °C for 
5 min, 50 °C for 60 min and 70 °C for 15 min. cDNA 
was then diluted 1:3 with DNase/RNase free water.
For qPCR analysis, 4 µL of diluted cDNA were 
combined with 6 µL of a mixture composed of 5 µL 1x 
SYBR Green master mix (Applied Biosystems), 0.4 µL 
each of 10 µM forward and reverse primers (Integrated 
DNA Technologies, Coralville, IA, USA), and 0.2 µL 
DNase/RNase free water in a MicroAmp™ Optical 
384-Well Reaction Plate (Applied Biosystems). Each 
sample was run in triplicate to control reproducibility 
of the essay and a 6 point relative standard curve 
(4-fold dilution) plus the non-template control were 
used  (User  Bulletin  #2, Applied  Biosystems,  CA). 
The reactions were performed in an ABI Prism 7900 
HT  SDS  instrument  (Applied  Biosystems)  using 
the following conditions: 2 min at 50 °C, 10 min at 
95 °C, 40 cycles of 15s at 95 °C, and 1 min at 60 °C. 
The presence of a single PCR product was verified by 
the dissociation protocol using incremental tempera-
tures to 95 °C for 15s plus 65 °C for 15s following the 
last cycle. Complete details regarding qPCR protocol 
Figure 1. Currently-known relationships among genes analyzed based on manually curated examination of the published literature within the Ingenuity 
Pathway Analysis® Knowledge Base. Upregulated (black background) and downregulated (white background) genes at d 21 relative to the start of 1X d 
milking (d 1) are shown for comparison. Gray background denotes that expression was not different between the time points.
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pebiodocs/04364014.pdf.  Data  were  analyzed  with 
the 7900 HT Sequence Detection Systems Software 
(version 2.2.3, Applied Biosystems).
Statistical analysis
Prior to statistical analysis all qPCR data were tested 
for normality using PROC Univariate of SAS (SAS 
Inst.,  Cary,  NC,  USA).  The  data  were  considered 
not normally distributed if the Shapiro-Wilk test had 
P # 0.05.20 All genes had a Shapiro-Wilk test with 
P , 0.05 and were normalized by log-transformation. 
The normalized log-transformed data were subjected 
to  PROC  REG  of  SAS  and  data  points  with 
studentized residuals .2.5 were considered outliers 
and removed from final analysis. The final dataset was 
analyzed using PROC MIXED in SAS. The statistical 
model consisted of time (ie, day relative to start of 1X 
daily milking) as a fixed effect and cow as random 
effect. Blood metabolite and insulin concentration, 
milk production, composition, and yield also were 
analyzed using PROC MIXED.
Results and Discussion
Physiological context
The cessation of milk removal begins the involution 
process  and  initially  results  in  distension  of  the 
mammary gland followed by a decline in the rate of 
milk secretion, an increase in intramammary pressure, 
a  decrease  in  mammary  blood  flow,  increased 
tight-junction  permeability  and  lactose  efflux,  and 
an  inflammatory  response.3,8,9  In  dairy  cattle,  these 
changes occur within 16 to 18 h of milk accumulation, 
are followed by complete cessation of milk secretion 
by approximately 30 h, and culminate with an increase 
in mammary epithelial cell apoptosis by 3 to 8 d after 
the last milking.8,21 Lactation can be fully restored in 
cows after 7 d without milking and partially restored 
after 11 d,22 implying that significant cell loss through 
apoptosis does not begin until after 7 d.
Recent  studies  have  used  transcriptomics  to 
examine genes and signaling pathways that are affected 
during  the  early  stages  (ie,  within  the  first  8  days 
of  cessation  of  milking)  of  mammary  involution  in 
non-pregnant lactating cows.8,9 It is implicit that the use 
of that type of model would allow the discovery of tissue 
factors that regulate the process of involution without 
the confounding effects of pregnancy-related hormones. 
The present experiment utilized non-pregnant cows at 
peak lactation (42 d post-partum; Fig. 2) and focused 
on the coordinated adaptations of genes across meta-
bolic  pathways,  immune  response,  oxidative  stress, 
and markers of apoptosis and cell proliferation during 
a 21 d period (Tables 1 and 2).
evaluation of ICG for normalization
We  have  previously  published  suitable  approaches 
for evaluation of ICG in bovine tissues.18,23 For the 
present study, we mined microarray data from these 
cows (P. Piantoni, S. L. Rodriguez-Zas, R. E. Everts,   
H. A. Lewin, W. L. Hurley, and J. J. Loor, unpub-
lished results) using the approaches outlined in our 
previous publications to identify 8 putative ICG (see 
supplemental  materials).  Aquaporin  11  (AQP11), 
eukaryotic  translation  initiation  factor  2B,  subunit   
2 beta (EIF2B2), SH3-domain GRB2-like endophilin 
B2 (SH3GLB2), S100 calcium binding protein A16 
(S100A16), mitochondrial GTPase 1 homolog (MTG1), 
mitochondrial  ribosomal  protein  L39  (MRPL39), 
ribosomal protein S15a (RPS15A), and protein phos-
phatase 1, regulatory (inhibitor) subunit 11 (PPP1R11) 
were initially selected for expression stability analy-
sis using geNorm. PPP1R11, MTG1, RPS15A, and 
MRPL39 were the most stable (see details of analysis 
in supplemental materials and Suppl. Figs. 2–4) using 
previously-published protocols18,23 and were used as 
ICG to normalize qPCR data. In addition, these genes 
were found to be suitable ICG in mammary paren-
chyma and stroma of pre-weaned calves.24
Mammary gland metabolism
Milk production and yields of milk fat, protein, and 
lactose decreased when cows were shifted from 2X to 
1X daily milking (Fig. 2 and supplemental material). 
These results and the numerical increase in milk SCC 
(supplemental  material)25  were  expected  responses. 
From a physiological standpoint, reduced milking fre-
quency represented a cue to signal lower mammary 
metabolic rate, hence, triggering systemic homeorhetic 
adaptations  favoring  use  of  nutrients  (eg,  glucose) 
for anabolic processes in other tissues. For example, 
greater  blood  insulin  and  insulin  sensitivity  would 
promote glucose use by adipose tissue and would pre-
vent lipolysis, leading to lower blood NEFA and their 
decreased availability for oxidation and ketogenesis in 
liver, in turn resulting in lower blood BHBA (Fig. 2).
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due to 1X daily milking were at least in part related 
to the gradual downregulation of the cluster of genes 
associated  with  fatty  acid  uptake  (CD36  molecule 
(thrombospondin  receptor),  CD36;  lipoprotein 
lipase,  LPL),  glucose  transport  (solute  carrier 
family 2 (facilitated glucose transporter), SLC2A1), 
lactose  synthesis  (alpha-lactalbumin,  LALBA), 
de novo fatty acid synthesis (acetyl-CoA carboxylase-
alpha,  ACACA;  fatty  acid  synthase,  FASN),  intra-
cellular  long-chain  fatty  acid  transport  (fatty  acid 
binding protein 3, FABP3), esterification (diacylglyc-
erol O-acyltransferase homolog 1, DGAT1), desatu-
ration (stearoyl-CoA desaturase, SCD; delta-6 fatty 
acid  desaturase,  FADS2),  and  lipid  droplet  forma-
tion (adipophilin, ADFP; butyrophilin, subfamily 1, 
member A1, BTN1A1; xanthine dehydrogenase, XDH) 
(Table  1).  The  expression  of  the  transporter ATP-
binding cassette, sub-family G (WHITE), member 2 
(ABCG2) also was gradually downregulated during 
cessation of milking, supporting its role as candidate 
gene for milk production traits.26 The reduction in 
mRNA expression of lipogenic enzymes was likely 
associated with a decrease in activity as shown recently 
for ACACA and FASN.7 Recent work with cows under 
a reduced milking   frequency protocol27 also found 
downregulation of beta casein (CSN2), kappa casein 
(CSN3),  and  LALBA  as  well  as  several  lipogenic 
genes.  Studies  of  mammary  involution  regulation 
in mice showed that downregulation of CSN2 dur-
ing milk stasis is a signature of increased locally-
produced  serotonin  (via  tryptophan  hydroxylase), 
which acts as an autocrine-paracrine signal regulat-
ing early   involution.28 Recent data support a simi-
lar mechanism in the bovine   mammary gland29 and 
revealed that LALBA also is a target of serotonin   
in vitro.30
Several of the lipogenic genes are controlled, at 
least in non-ruminants, by a transcriptional network 
encompassing  peroxisome  proliferator-activated 
receptor gamma (PPARG), sterol regulatory element 
binding  transcription  factor  1  (SREBF1),  and 
SREBF2 (Fig. 1). We have previously shown that 
PPARG expression in bovine mammary increases at 
the onset and throughout lactation, and may partly 
account  for  the  concomitant  upregulation  of  both 
SREBF1 and SREBF2.31 The fact that PPARG expres-
sion was not affected during cessation of milking 
does not argue against a role for this nuclear recep-
tor in activating the mammary lipogenic program 
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Figure 2. Milk production, lactose yield, and blood metabolites and insulin during 1X milking (d 1 to 5) or after cessation of milking (d 5 to 21). Different 
letters denote significant effects (P , 0.05) due to day relative to induction of involution.
Piantoni et al
90  Bioinformatics and Biology Insights 2010:4because  we  demonstrated  that  the  PPARγ-specific 
ligand rosiglitazone led to upregulation of SREBF1 
and a number of lipogenic genes without affecting 
PPARG  expression.32  The  downregulation  of  the 
putative PPARγ targets SREBF1, ACACA, FASN, and 
DGAT1 (Table 1) provides additional support for a 
role of this nuclear receptor in regulation of milk fat 
synthesis during lactation.31 In rodents evidence indi-
cates that SREBF2 can regulate expression of several 
lipogenic genes,33 ie, it overlaps in that function with 
SREBF1 (eg, Fig. 1). Our results support the idea 
that both transcription factors may have overlapping 
functions during milk fat synthesis. Together with 
previous  data,31,32  we  provide  further  evidence  of 
the central role of PPARG, SREBF1 and SREBF2 in 
mammary epithelial cells during lactation.
The  upregulation  of  ATP-citrate  lyase  (ACLY) 
after cessation of milking was unexpected because, 
although  this  enzyme  is  not  the  primary  source 
of  cytosolic  acetyl-CoA  in  ruminant  mammary 
cells,34  in  non-ruminants  it  furnishes  acetyl-CoA 
from  citrate  during  lipogenesis.34  With  the  recent 
discovery  that ACLY  is  required  for  increases  in 
histone  acetylation  (a  mechanism  of  transcription 
regulation)  in  response  to  growth  factor  stimula-
tion and cellular differentiation,35 ACLY upregula-
tion may be a mechanism in the developing stromal 
tissue (eg,15) to generate acetyl-CoA from glucose 
carbon  for  histone  acetylation,  thus,  participating 
in the underlying transcriptional regulation associ-
ated with involution. It remains to be determined 
which growth factor (eg, TGF-β), if any, controls 
Table 1. Expression profiles in mammary tissue of genes associated with milk component synthesis during a shift from 2X 
to 1X daily milking (day 1 to 5) followed by complete cessation of milking (day 5 to 21).
Gene  
category
cellular function Day relative to induction of involution seM P =
1 5 14 21
Milk fat synthesis Log-transformed mrNA abundance
  ACACA de novo FA synthesis 4.82a 4.23ab 3.78bc 3.50c 0.24 0.03
  ACSL1 FA acid activation 4.58a 4.50ab 4.15ab 3.97b 0.17 0.09
  ACLY Cytosolic citrate synthesis 3.93a 4.16a 4.57b 4.70b 0.12 0.01
  ADFP Lipid droplet formation 4.92a 4.45a 3.69b 3.44b 0.24 0.02
  BTN1A1 Lipid droplet formation 4.63a 4.07ab 2.81bc 2.09c 0.48 0.03
  CD36 FA uptake 4.67a 4.24ab 3.55c 3.37c 0.26 0.03
  DGAT1 Esterification 4.49a 4.33ab 4.23b 4.31ab 0.08 0.04
  DGAT2 Esterification 4.03 4.41 4.48 4.48 0.21 0.37
  FABP3 Intracellular FA transport 4.83a 3.89ab 3.01b 2.59b 0.42 0.03
  FADS1 Delta-6 desaturation 4.40a 3.63ab 3.11b 2.94b 0.35 0.03
  FASN de novo FA synthesis 4.57a 3.86ab 3.19b 2.90b 0.36 0.05
  GPAM Esterification 4.11 4.12 3.57 3.04 0.39 0.19
  INSIG1 Lipogenesis regulation 4.02 3.76 3.51 2.93 0.30 0.11
  LPL Blood triacylglycerol hydrolysis 4.78a 4.03ab 3.14b 2.84b 0.42 0.04
  PPARG Transcription regulation 3.79 3.88 3.89 4.02 0.11 0.39
  SCAP SreBF chaperone 4.07a 4.14ab 4.21b 4.27b 0.05 0.08
  SCD Delta-9 desaturation 4.16a 3.57ab 2.63b 1.94b 0.50 0.05
  SLC2A1 Glucose transport 4.11a 3.85a 3.36b 3.24b 0.16 0.02
  SREBF1 Transcription regulation 4.66a 4.55a 3.80b 3.60b 0.20 0.01
  SREBF2 Transcription regulation 4.07a 3.93ab 3.82bc 3.62c 0.10 0.02
  THRSP Transcription regulation 4.37ab 4.38a 4.17b 4.22ab 0.10 0.09
  XDH Lipid droplet formation 4.49a 4.25ab 3.65bc 3.17c 0.24 0.04
Milk protein and lactose synthesis
  CSN2 Beta casein synthesis 2.23a 1.91ab 1.34b 1.27b 0.33 0.07
  CSN3 Kappa casein synthesis 3.78a 3.42ab 2.97b 2.61b 0.25 0.06
  LALBA Alpha lactalbumin synthesis 3.55a 3.18a 1.96b 1.99ab 0.55 0.05
  LTF Lactotransferrin synthesis 3.19a 3.79b 4.93c 4.79c 0.17 0.0002
  LYZ1 Lysozyme 1 synthesis 3.37 3.25 3.89 3.97 0.23 0.16
Milk production
  ABCG2 Transport 4.53a 4.17ab 3.34b 3.16b 0.32 0.03
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involution.
Transcription regulators of apoptosis  
and cell proliferation
It  is  well-accepted  that  during  the  process  of 
involution there is an increase in epithelial cell death 
through  apoptosis  and  autophagy.6,7,21 Apoptosis  of 
epithelial cells assessed by degree of DNA fragmen-
tation can already be seen at 1 wk after cessation of 
milking.21  Consistent  with  the  fact  that  significant 
cell loss by apoptosis does not occur until approxi-
mately 7 d after cessation of milking, the trend for 
upregulation of both STAT3 and MYC was evident 
at d 5 and continued through d 14 (Table 2). It has 
been speculated that STAT336 regulates expression of 
MYC (Fig. 1), which may have potentiated apopto-
sis in the present study. It also appears that the pro-
apoptotic effect of STAT3 is blocked by activation 
of the PI-3 K/Akt signaling pathway, which would 
partly  explain  the  opposite  expression  patterns  of 
v-akt  murine  thymoma  viral  oncogene  homolog  1 
(AKT1) and both STAT3 and MYC. AKT1 has been 
associated with mammary cell proliferation.37 It also 
seems possible that in the absence of a stimulus for 
milk protein synthesis upon cessation of milking, the 
degree of insulin sensitivity in mammary tissue was 
reduced and allowed for apoptosis and remodeling 
Table 2. Expression profiles in mammary tissue of genes associated with regulation of apoptosis, tissue remodeling, 
and immune response during a shift from 2X to 1X daily milking (day 1 to 5) followed by complete cessation of milking   
(day 5 to 21).
Gene  
category
cellular function/biological process Day relative to induction  
of involution
seM P =
1 5 14 21
Apoptosis/cell proliferation Log-transformed mrNA abundance
  STAT3 Transcription regulation 3.90a 4.11a 4.40b 4.42b 0.06 0.01
  MYC Transcription regulation 3.75a 3.85a 4.36b 4.44b 0.12 0.01
  AKT1 Protein kinase activity 3.67a 3.71a 3.52b 3.47b 0.06 0.01
  MTOR Protein kinase activity 4.17a 4.15a 4.27b 4.28b 0.05 0.02
  TGFB1 Growth factor/transcription regulation 4.23a 4.40b 4.60c 4.36ab 0.07 0.009
  TGFBR1 TGFB binding 4.28a 4.60b 4.65b 4.37a 0.07 0.001
  JAG1 Notch binding/growth factor activity 4.03a 4.06ab 4.37c 4.30bc 0.08 0.02
  CLU Protein binding 2.79a 3.09a 4.28b 4.47b 0.18 0.002
  IGFBP3 Insulin-like growth factor binding 4.14a 3.97a 4.56b 4.45b 0.09 0.002
  IGFBP5 Insulin-like growth factor binding 3.79 3.98 3.89 3.71 0.12 0.30
  MUC1 Apoptosis/anti-inflammatory response 4.59a 4.62a 3.63b 4.00b 0.22 0.007
  S100A10 Calcium ion binding/actin filament organization 3.61a 3.93b 4.38c 4.39c 0.10 0.008
  PIGT Protein binding/attachment of GPI anchor 4.11a 4.20a 4.37b 4.45b 0.04 0.003
  CALR Calcium ion binding/transcription regulation 4.32a 4.15c 4.31ab 4.18bc 0.05 0.04
DNA damage and tissue remodeling
  CAPNS1 Calcium ion binding/protein binding 3.90a 4.20b 4.29b 4.25b 0.07 0.01
  CSNK2A2 Protein binding/kinase activity 4.17a 4.30b 4.27b 4.30b 0.03 0.01
  SAT1 Polyamine biosynthesis 3.56a 4.23b 4.30b 4.28b 0.09 0.005
  EEF1A1 Nucleotide binding/translation elongation 4.21a 4.39b 4.31ab 4.35ab 0.05 0.06
  MMP2 Peptidase activity 3.86a 4.14ab 4.37b 4.34b 0.11 0.03
  CTSC Peptidase activity 3.08a 3.35b 4.34c 4.72c 0.19 0.01
  FSTL3 Activin binding/protein binding 3.92a 3.99a 4.47b 3.95b 0.16 0.009
  F2R Thrombin binding 4.40a 4.15a 3.73b 3.66b 0.11 0.01
Immune and oxidative stress response
  TNF Cytokine activity/transcription regulation 3.50a 4.19b 4.08b 4.27b 0.17 0.05
  SAA3 Neutrophil/macrophage chemotaxis 1.75a 2.45a 3.92b 4.58b 0.41 0.02
  HP endopeptidase activity/defense response 4.22 4.30 4.84 4.59 0.33 0.28
  C3 Complement activation/inflammation 3.22a 3.81b 4.12b 3.87ab 0.22 0.04
  GPX1 Oxidoreductase activity/redox homeostasis 3.95a 4.18ab 4.42c 4.37bc 0.09 0.02
  SOD2 Oxidoreductase activity/anti-apoptosis 3.45a 3.92a 4.74b 4.90b 0.19 0.01
  SPP1 Cytokine activity/inflammation 2.88a 3.15a 4.40b 4.16b 0.17 0.001
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AKT1,38 supports the existence of a regulatory loop 
encompassing STAT3 and MYC in bovine mammary 
cells, which controls the process of apoptosis during 
milk stasis.
Both  genomic  and  functional  analyses  of 
MYC  targets  suggest  that  while  it  behaves  as  a 
global  regulator  of  transcription,  groups  of  genes 
involved in cell cycle regulation, metabolism, ribo-
some  biogenesis,  protein  synthesis,  and  mitochon-
drial  function  are  over-represented  in  the  MYC 
target-gene  network.39  In  a  metabolic  context,  the 
well-established upregulation of glycolytic and lipo-
genic (eg, FASN) gene expression in rat and human 
cells induced by MYC overexpression would furnish 
the energy required for cellular growth provided that 
there is an appropriate supply of substrates (eg, glu-
cose) and growth factors.39 In the absence of nutrients 
or growth factors, the upregulation of MYC predis-
poses cells to apoptosis and would partly explain its 
role in mammary involution, ie, cessation of milk-
ing  reduced  mammary  metabolic  activity  causing 
reduced  glucose  uptake  (and  hence  greater  blood 
glucose   concentration, Fig. 2).
Although not a MYC target gene the expression 
of  secreted  phosphoprotein  1  (SPP1)  is  high  in 
mammary of MYC-transgenic mice and also during 
lactation and involution vs. pregnancy.40 Expression 
of SPP1 seems to be associated with mammary gland 
morphogenesis in rodents, and it is a negative regulator 
of matrix metallopeptidase 2 (MMP2) expression and 
activity.41 Our data (Table 2), however, showed that 
both SPP1 and MMP2 were gradually upregulated 
during cessation of milking, which indicates that their 
expression  may  be  required  for  bovine  mammary 
tissue  remodeling  during  the  course  of  involution. 
A recent study with mice also found gradual upregu-
lation of MMP2 in mammary tissue during the first 
72 h after weaning.42 The increase in MMP2 mRNA 
is characteristic of the remodeling process that leads 
to destruction of the basement membrane, effectively 
allowing the tissue to return to a pre-pregnant state.42 
The “normal” course of murine mammary involution 
also was characterized by greater STAT3 mRNA and 
activity, greater caspase-3 activity, and more impor-
tantly a robust pro-inflammatory and oxidative-stress 
response (see discussion below) triggered in part by 
pronounced nitric oxide synthesis.42
Among  the  large  number  of  genes  it  regulates, 
there is evidence that mechanistic target of rapamycin 
(serine/threonine kinase) (MTOR) (formerly known 
as “mammalian target of rapamycin”) also may be a 
MYC target38 and our results seem to support that view. 
The MTOR gene encodes a nutrient-sensitive protein 
kinase,  which  under  normal  conditions  regulates 
cell growth and mitotic cell division in response to 
glucose and insulin availability.43,44 It also seems to 
play  a  role  in  the  regulation  of  bovine  mammary 
protein  synthesis  during  lactation.45  Based  on  the 
expression patterns and biological roles of STAT3, 
MYC, and MTOR (Table 2), the MTOR protein may 
have elicited effects on non-epithelial cellular prolif-
eration (eg, stromal fibroblasts) through induction of 
STAT3 and MYC.46 From the present data it seems 
possible that AKT1 in bovine mammary may not be 
responsive to MTOR (Table 2), but rather it may be 
associated with milk protein induction during lacta-
tion in response to insulin47 or IGF-1.48
Transforming growth factor beta network
Transforming growth factor, beta 1 (TGFB1) signaling 
occurs by binding of the growth factor to transforming 
growth factor, beta receptor II (TGFBR2), which acti-
vates and binds to the structurally-similar TGFBR1.49 
Both TGFB1 and TGFBR1 expression were signifi-
cantly upregulated by d 5 of 1X daily milking but 
TGFB1 reached peak upregulation at d 14 (ie, 9 d from 
cessation of milking; Table 2), potentially coinciding 
with a gradual increase in stromal fibroblasts.15 Unlike 
previously thought,49 our data suggest that TGFB1 in 
mammary tissue of high-producing dairy cows plays 
an important role in the later stages of involution. The 
profile of expression of both TGFB1 and TGFBR1, 
ie, a gradual increase followed by a return to basal 
expression,  suggests  a  link  with  follistatin-like  3 
(secreted glycoprotein) (FSTL3) and the control of 
TGFB1 ligand availability (see discussion below).
The expression of TGFB1 and TGFBR1 coincided 
with the expression of STAT3 and MYC (Table 2). As 
previously reported in rodent mammary cells, marked 
elevation of jagged 1 (JAG1) and clusterin (CLU) by 
d 14 and 21 may have been induced by TGFB1.50,51 
A previous study of the early stages of bovine mammary 
involution reported an increase in CLU.9   Jagged 1 is the 
ligand for the receptor Notch 1, which upon activation 
by MTOR signaling prevents   cellular differentiation 
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human breast cancer cells.52 Our data on JAG1 and 
MTOR  expression  suggest  that  perturbation  of  cell 
differentiation by augmented Notch signaling might 
be a mechanism during involution to control cellular 
differentiation  during  mammary  tissue  remodelling. 
Recent  studies  have  shown  that  TGFB1  activation 
in  murine  mammary  cancer  cells  results  in  marked 
upregulation of CLU as well as secretion of the protein, 
which serves to mediate the epithelial-to-mesenchymal 
transition.53 Such a close relationship likely explains 
the similar pattern of expression of TGFB1 and CLU 
(Table  2).  Our  data  would  suggest  that  Notch  and   
MTOR signaling and CLU synthesis allow the comple-
tion of extracellular mammary tissue remodeling during 
the final stages of involution when TGFB1 and TGFBR1 
expression return to the basal levels (Table 2).
The parallel upregulation of TGFB1 and TGFBR1 
expression  supports  the  well-accepted  view  that 
mammary-derived signals in response to milk stasis 
activate programmed cell death during the first stage 
of mammary gland involution.49 Interestingly, we did 
not observe an upregulation of insulin-like growth 
factor binding protein 5 (IGFBP5) (Table 2) which 
has  been  proposed  as  a  potent  apoptosis  factor.27 
However,  in  the  present  study  the  upregulation  of 
IGFBP3, partly via a pro-inflammatory state induced 
by cytokines54 such as tumor necrosis factor (TNF) 
(see section below), might have compensated for the 
lack of change in IGFBP5.
Gene markers of cellular senescence, 
DNA damage, and tissue remodeling
In human fibroblasts, calpain, small subunit 1 (CAPNS1), 
which  can  initiate  MYC  expression,  was  linked  to 
cellular senescence induced in vitro by DNA damage.55 
CAPNS1 is an intracellular calcium-dependent cysteine 
protease  that  belongs  to  the  calpain  family  and  is 
involved  in  remodeling  of  cytoskeletal/membrane 
attachments,  degradation  of  enzymes  that  control 
progression  through  the  cell  cycle,  and  apoptosis.56 
Casein kinase 2 (CSNK2A2) contributes to the radia-
tion-induced senescence of human mesenchymal stem 
cells57 and also forms part of the TGFB1 signaling net-
work (Fig. 1) that elicits the dissolution of tight junc-
tions  during  epithelial-to-mesenchymal  transitions.58 
Spermidine/spermine N1-acetyltransferase (SAT1) can 
increase apoptosis through regulating cytosolic levels 
of spermidine and spermine9,27 and its expression is 
markedly upregulated during murine involution.59 In 
human cancer cells, eukaryotic translation elongation 
factor 1 alpha 1 (EEF1A1) has been identified as a novel 
marker of cellular senescence whose downregulation 
induces a novel, caspase-independent mechanism of 
apoptosis to eliminate abnormal tetraploid cells and 
inhibit  tumorigenesis.60  We  observed  peak  upregu-
lation of all of these genes by day 5 of 1X milking 
(Table 2) suggesting that temporary milk stasis was a 
strong stimulus potentially due to an increase in DNA 
fragmentation as has been previously observed in invo-
luting bovine and murine mammary tissue.21
In the present study, marked changes in expression 
of genes involved in tissue remodeling were observed 
through each phase of involution, ie, peak upregulation 
of CAPNS1 by d 5 followed by gradual upregulation 
of  MMP2,  cathepsin  C  (CTSC;  a  peptidase),  and 
FSTL3 by d 14 (Table 2). The observed upregulation 
of MMP2 has been reported previously in involuting 
bovine mammary61 and agrees with the demonstrated 
effect  of  the  protein  on  mammary  tissue  structure 
during  involution.42  CTSC  is  an  exopeptidase  that 
can be found intracellularly in lysosomes or in exo-
cytic vesicles and it is involved in the activation of 
proteinases in immune cells.62 FSTL3 acts through its 
binding to members of the TGFB superfamily such 
as activin and it also has an NF-kappaB response ele-
ment that allows for TNF to upregulate its expres-
sion.63 Furthermore, TGFB1 potentiates the effect of 
TNF on FSTL3 expression through Smad proteins. 
Recent data have shown that FSTL3 mRNA is par-
ticularly high in stromal-vascular tissue of adipose 
tissue,  and  can  be  secreted  by  this  tissue  at  least   
in vitro.64 Because of this novel property it has been 
classified as a new adipokine,64 just as leptin and adi-
ponectin. It could be possible that the upregulation of 
FSTL3 we observed corresponded with an increase in 
stromal tissue development (eg,15). More importantly, 
the sustained upregulation of FSTL3 may represent 
a mechanism whereby mammary cells secrete this 
protein as a mechanism to bind TGFB ligands, thus, 
exerting control over the activity of the growth fac-
tor. In fact, the pattern of TGFB1 expression (Fig. 2) 
may have been a consequence of more FSTL3 pro-
tein sequestering TGFB1 ligand (eg, avidin), ie, there 
was no feed-forward regulator for sustained synthesis 
of TGFB1.
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response genes
Studies  with  rodents  have  clearly  shown  an 
upregulation of acute-phase response genes involving 
STAT3, NF-kappaB, and nitric oxide production during 
the early phase of involution.42,59 Thus, our finding of 
TNF upregulation during 1X milking and its sustained 
elevation through d 21 (Table 2) indicates that, just as 
in rodents, cytokines play a role in bovine mammary 
tissue remodeling, eg, through activation of MMP2.42 
The finding of sustained TNF and SAA3 coupled with 
that of glutathione peroxidase 1 (GPX1) and superox-
ide dismutase 2, mitochondrial (SOD2) through d 21 
(ie, ~17 days from cessation of milking; Table 2) are 
indicative of a pronounced state of local inflammation 
and oxidative stress even at the latter stages of invo-
lution. A pro-inflammatory state in bovine mammary 
epithelial cells either may contribute to or may be a 
consequence of lactotransferrrin (LTF) upregulation 
(Table 1) and synthesis after cessation of milking.65 It 
is evident, however, that LTF can assist the involution 
process  by  reducing  viability  of  bovine  mammary 
epithelial cells (eg, through caspase activation) and 
by  inhibiting  synthesis  of  caseins  (CSN2,  CSN3) 
through a mechanism partly involving upregulation 
of IL-1β.65 It appears likely that other cytokines such 
as TNF and SPP1 participate in the overall inhibition 
of mammary epithelial cell viability.
Just as hypothesized in rodents,59 a key function of 
STAT3 during bovine mammary involution is to trigger 
an acute-phase response (ie, SAA3 is one direct target;)66 
not only to counteract the pro-inflammatory state but 
to promote phagocytosis of apoptotic cells that arise 
during the remodeling process.59 Therefore, our data 
support the view that STAT3 activity during involu-
tion promotes apoptosis and guides tissue remodelling 
while protecting the tissue from excessive damage.66 
It remains to be determined whether an endogenous 
acute-phase protein feed-back activates STAT3 as has 
been proposed for orosomucoid in murine   mammary.59 
In this context it is possible that CLU may play an 
anti-inflammatory role either by promoting synthesis 
of acute-phase proteins67 or by directly inhibiting NF-
kappaB signaling.68 Because expression of HP was not 
affected significantly during the study (Table 2), it is 
unlikely that it participates in the acute-phase response 
during involution as it does in the rodent mammary 
gland.66 It also is possible that upregulation of CLU 
may help reduce the production of reactive oxygen 
species69 that trigger upregulation of GPX1 and SOD2 
(Table 2). Because CLU, like STAT3, is a direct target 
of TGFB1,53,70 this growth factor may have dual func-
tions during involution, ie, promoting apoptosis and 
preventing excessive cellular damage by downregulat-
ing NF-kappaB signaling through CLU.
The  presence  of  a  sustained  pro-inflammatory 
and oxidative stress state in bovine mammary differs 
substantially  from  the  situation  in  rodents.49  This 
may  be  indicative  of  inherent  species  differences 
potentially linked with mammary metabolic capacity. 
At the histological level, such a pronounced inflam-
matory  response  and  the  corresponding  pattern  of 
TGFB1 would suggest a substantial influx of neutro-
phils and macrophages recruited to remove cellular 
debris during tissue remodeling.49 Our data confirmed 
that genes related to the immune response are upregu-
lated during early stages of bovine mammary involu-
tion9 and extend those findings to show the presence 
of  a  robust  pro-inflammatory  and  oxidative  stress 
response even after ~3 weeks from the cessation of 
milking. We propose that such a response is partly 
driven by differences in mammary metabolic capacity 
and/or genetic merit, ie, cessation of milking at peak 
lactation would likely require a lengthier process of 
remodeling due to the presence of greater numbers 
of epithelial cells. The transcription factor STAT3, as 
in rodent mammary, apparently links cellular immune 
responses with growth and proliferation and strength-
ens its fundamental role in the process of involution.
Summary
Mammary gland involution is a complex process that 
is dependent on interactions between the mammary 
epithelium  and  the  surrounding  stromal  tissues.49 
Our data demonstrated orchestrated upregulation of 
apoptosis,  tissue  remodeling,  and  inflammation  in 
mammary tissue accompanied by reduced biosynthesis 
of milk components (ie, milk protein, fat and lactose) 
(Fig.  2)  due  to  the  reduction  in  metabolic  activity 
induced by reduction and cessation of milking, which 
triggered mammary involution. As in rodents, the tran-
scription factor STAT3 as well as TGFB1 appear to 
play central roles during mammary involution through 
temporal-spatial  regulation  of  apoptosis  as  well  as 
inflammation  and  oxidative  stress.  Coincident  with 
the stage-dependent characteristics of involution,8,22 
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upregulation of TGFB1 between d 1 and 14 followed 
by its downregulation between d 14 and 21. However, 
unlike rodents, inflammation and oxidative stress per-
sisted well-beyond the point of milk stasis potentially 
due to the substantial amount of epithelial tissue in the 
mammary gland of these cows at peak lactation.
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